7.54
price up icon0.27%   0.02
after-market Handel nachbörslich: 7.52 -0.02 -0.27%
loading

Finanzdaten der Nuvectis Pharma Inc-Aktie (NVCT)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Research and Development
37.63%
2.66
4.265 4.486 4.262 2.367
Operating Income/Loss
35.97%
-4.396
-6.866 -6.158 -5.772 -4.101
Income/Loss From Continuing Operations Before Tax
37.01%
-4.171
-6.622 -5.881 -5.708 -4.049
Income/Loss From Continuing Operations After Tax
37.01%
-4.171
-6.622 -5.881 -5.708 -4.049
Net Income/Loss
37.01%
-4.171
-6.622 -5.881 -5.708 -4.049
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
7,603%
16.56
0.215 16.10 15.18 14.72
Diluted Average Shares
7,603%
16.56
0.215 16.10 15.18 14.72
Basic Earnings Per Share
39.02%
-0.25
-0.41 -0.37 -0.38 -0.27
Diluted Earnings Per Share
39.02%
-0.25
-0.41 -0.37 -0.38 -0.27
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$20.30
price down icon 0.68%
$36.37
price up icon 0.50%
$24.55
price up icon 8.53%
$97.80
price down icon 0.45%
$110.00
price up icon 1.61%
biotechnology ONC
$245.49
price up icon 0.48%
Kapitalisierung:     |  Volumen (24h):